SCHEMBL7050899

SCHEMBL7050899

CC(=O)N(C)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL813440 0.78
SCHEMBL4012293 0.75
SCHEMBL10918764 0.75
SCHEMBL19092117 0.75
SCHEMBL1925147 0.73 ALDH1A1 (0.50)
SCHEMBL1332099 0.73
SCHEMBL30581182 0.73
SCHEMBL4820393 0.73
SCHEMBL30581185 0.73
SCHEMBL1190178 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154905-A1 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS GILEAD SCIENCES, INC. (US) 2023-08-17 WO disclosed
CN-103732567-A Dihydrofuran derivatives as pesticidal compounds SYNGENTA PARTICIPATIONS AG 2014-04-16 CN disclosed
WO-2012142659-A1 SITE-SELECTIVE MODIFICATION OF PROTEINS BAKER IDI HEART AND DIABETES INSTITUTE HOLDINGS LIMITED (AU) 2012-10-26 WO disclosed
EP-2397469-A1 Diarylhydantoin compounds The Regents Of the University of California (US) 2011-12-21 EP disclosed
EP-1798230-A1 Substituted alkylamine derivatives and methods of use Amgen Inc. (US) 2007-06-20 EP disclosed
WO-2003028731-A1 CHK1 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-04-10 WO disclosed